메뉴 건너뛰기




Volumn 9, Issue 5, 2009, Pages 583-600

A fuller understanding of pancreatic neuroendocrine tumours combined with aggressive management improves outcome

Author keywords

Carcinoid; Endocrine tumours; Gastrinoma; Gastroenteropancreatic system; Glucagonoma; Insulinoma; Islet cell; Neuroendocrine tumours; Pancreas; Vipoma

Indexed keywords

ALPHA INTERFERON; ANGIOPEPTIN; ANTINEOPLASTIC AGENT; CHLOROZOTOCIN; CHORIONIC GONADOTROPIN ALPHA SUBUNIT; CHROMOGRANIN A; CHROMOGRANIN B; CISPLATIN; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; KI 67 ANTIGEN; LUTETIUM 177; NEURON SPECIFIC ENOLASE; NEUROPILIN 2; OCTAPEPTIDE; OCTREOTIDE; SECRETOGRANIN II; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; STREPTOZOCIN; SYNAPTOPHYSIN; TUMOR MARKER; VASCULOTROPIN INHIBITOR; VATALANIB; YTTRIUM 90;

EID: 68049102990     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000212085     Document Type: Review
Times cited : (40)

References (130)
  • 2
    • 33845943674 scopus 로고    scopus 로고
    • Surgical experiences of functioning neuroendocrine neoplasm of the pancreas
    • Kang C, Park S, Kim K, Choi J, Lee W, Kim B: Surgical experiences of functioning neuroendocrine neoplasm of the pancreas. Yonsei Med J 2006; 47: 833-839.
    • (2006) Yonsei Med J , vol.47 , pp. 833-839
    • Kang, C.1    Park, S.2    Kim, K.3    Choi, J.4    Lee, W.5    Kim, B.6
  • 3
    • 0033961569 scopus 로고    scopus 로고
    • Neuroendocrine tumours of the pancreas
    • Eriksson B, Oberg K: Neuroendocrine tumours of the pancreas. Br J Surg 2000; 87: 128-131.
    • (2000) Br J Surg , vol.87 , pp. 128-131
    • Eriksson, B.1    Oberg, K.2
  • 5
    • 0033670407 scopus 로고    scopus 로고
    • Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: Surgery or surveillance?
    • Bartsch D, Langer P, Wild A, Schilling T, Celik I, Rothmund M, et al: Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery 2000; 128: 958-966.
    • (2000) Surgery , vol.128 , pp. 958-966
    • Bartsch, D.1    Langer, P.2    Wild, A.3    Schilling, T.4    Celik, I.5    Rothmund, M.6
  • 6
    • 0026709377 scopus 로고
    • Pancreatic tumors in multiple endocrine neoplasia type 1: Clinical presentation and surgical treatment
    • Grama D, Skogseid B, Wilander E, Eriksson B, Martensson H, Cedermark B, et al: Pancreatic tumors in multiple endocrine neoplasia type 1: Clinical presentation and surgical treatment. World J Surg 1992; 16: 611-618.
    • (1992) World J Surg , vol.16 , pp. 611-618
    • Grama, D.1    Skogseid, B.2    Wilander, E.3    Eriksson, B.4    Martensson, H.5    Cedermark, B.6
  • 7
    • 20244363474 scopus 로고    scopus 로고
    • Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel- Lindau disease
    • Libutti S, Chouyke P, Alexander H, Glenn G, Bartlett D, Zbar B, et al: Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel- Lindau disease. Surgery 2000; 128: 1022-1027.
    • (2000) Surgery , vol.128 , pp. 1022-1027
    • Libutti, S.1    Chouyke, P.2    Alexander, H.3    Glenn, G.4    Bartlett, D.5    Zbar, B.6
  • 10
    • 33746326828 scopus 로고    scopus 로고
    • Neuroendocrine tumors of the pancreas, excluding gastrinoma
    • Stephen A, Hodin R: Neuroendocrine tumors of the pancreas, excluding gastrinoma. Surg Oncol Clin North Am 2006; 15: 497-510.
    • (2006) Surg Oncol Clin North Am , vol.15 , pp. 497-510
    • Stephen, A.1    Hodin, R.2
  • 11
    • 0028625751 scopus 로고
    • The neurotransmitter concept today
    • Langley K: The neurotransmitter concept today. Ann NY Acad Sci 1994; 733: 1-17.
    • (1994) Ann NY Acad Sci , vol.733 , pp. 1-17
    • Langley, K.1
  • 13
    • 0034919116 scopus 로고    scopus 로고
    • Insulinoma of the pancreas with insular-ductular differenctiation in its liver metastasis - Indication of a common stem-cell origin of the exocrine and endocrine components
    • Regitnig P, Spuller E, Denk H: Insulinoma of the pancreas with insular-ductular differenctiation in its liver metastasis - indication of a common stem-cell origin of the exocrine and endocrine components. Virchows Arch 2001; 438: 624-628.
    • (2001) Virchows Arch , vol.438 , pp. 624-628
    • Regitnig, P.1    Spuller, E.2    Denk, H.3
  • 14
    • 26844517731 scopus 로고    scopus 로고
    • Introduction: Definition, historical aspects, classification, staging, prognosis and therapeutic options
    • Arnold R: Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options. Best Pract Res Clin Gastroenterol 2005; 19: 491-505.
    • (2005) Best Pract Res Clin Gastroenterol , vol.19 , pp. 491-505
    • Arnold, R.1
  • 15
    • 0000075526 scopus 로고
    • Simple adenoma of pancreas arising from an islet of Langerhans
    • Nicholls A: Simple adenoma of pancreas arising from an islet of Langerhans. J Med Res 1902; 8: 385-395.
    • (1902) J Med Res , vol.8 , pp. 385-395
    • Nicholls, A.1
  • 16
    • 0000260146 scopus 로고
    • Karzinoide tumoren des dunndarms
    • Oberndorfer S: Karzinoide Tumoren des Dunndarms. Frankf Z Pathol 1907; 1: 426.
    • (1907) Frankf Z Pathol , vol.1 , pp. 426
    • Oberndorfer, S.1
  • 17
    • 0014510423 scopus 로고
    • The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept
    • Pearse A: The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept. J Histochem Cytochem 1969; 17: 303-313.
    • (1969) J Histochem Cytochem , vol.17 , pp. 303-313
    • Pearse, A.1
  • 18
    • 2342666214 scopus 로고    scopus 로고
    • The gastroenteropancreatic neuroendocrine cell system and its tumors: The WHO classification
    • Kloppel G, Perren A, Heitz P: The gastroenteropancreatic neuroendocrine cell system and its tumors: The WHO classification. Ann NY Acad Sci 2004; 1014: 13-27.
    • (2004) Ann NY Acad Sci , vol.1014 , pp. 13-27
    • Kloppel, G.1    Perren, A.2    Heitz, P.3
  • 20
    • 0038177939 scopus 로고    scopus 로고
    • Malignant carcinoids in the USA, SEER 1992-1999. An epidemiological study with 6,830 cases
    • Crocetti E, Paci E: Malignant carcinoids in the USA, SEER 1992-1999. An epidemiological study with 6,830 cases. Eur J Cancer Prev 2003; 12: 191-194.
    • (2003) Eur J Cancer Prev , vol.12 , pp. 191-194
    • Crocetti, E.1    Paci, E.2
  • 21
    • 33749032826 scopus 로고    scopus 로고
    • TNM staging of foregut (neuro)endocrine tumors: A consensus proposal including a grading system
    • Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, De Herder W, et al: TNM staging of foregut (neuro)endocrine tumors: A consensus proposal including a grading system. Virchows Arch 2006; 449: 395-401.
    • (2006) Virchows Arch , vol.449 , pp. 395-401
    • Rindi, G.1    Kloppel, G.2    Alhman, H.3    Caplin, M.4    Couvelard, A.5    De Herder, W.6
  • 22
    • 43549103792 scopus 로고    scopus 로고
    • Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas
    • Fischer L, Kleeff J, Esposito I, Hinz U, Zimmermann A, Friess H, et al: Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg 2008; 95: 627-635.
    • (2008) Br J Surg , vol.95 , pp. 627-635
    • Fischer, L.1    Kleeff, J.2    Esposito, I.3    Hinz, U.4    Zimmermann, A.5    Friess, H.6
  • 23
    • 33846451046 scopus 로고    scopus 로고
    • Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: An institutional experience
    • Schurr PG, Strate T, Rese K, Kaifi JT, Reichelt U, Petri S, et al: Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: An institutional experience. Ann Surg 2007; 245: 273-281.
    • (2007) Ann Surg , vol.245 , pp. 273-281
    • Schurr, P.G.1    Strate, T.2    Rese, K.3    Kaifi, J.T.4    Reichelt, U.5    Petri, S.6
  • 25
    • 0033843657 scopus 로고    scopus 로고
    • Tumor markers in neuroendocrine tumors
    • Eriksson B, Oberg K, Stridsberg M: Tumor markers in neuroendocrine tumors. Digestion 2000; 62(suppl 1):33-38.
    • (2000) Digestion , vol.62 , Issue.SUPPL. 1 , pp. 33-38
    • Eriksson, B.1    Oberg, K.2    Stridsberg, M.3
  • 26
    • 0033660553 scopus 로고    scopus 로고
    • Roles of gastrointestinal hormones in pancreatic cancer
    • Guo Y, Townsend CJ: Roles of gastrointestinal hormones in pancreatic cancer. J Hepatobiliary Pancreat Surg 2000; 7: 276-285.
    • (2000) J Hepatobiliary Pancreat Surg , vol.7 , pp. 276-285
    • Guo, Y.1    Townsend, C.J.2
  • 27
    • 0022527025 scopus 로고
    • Gastroenteropancreatic neuroendocrine tumors. A histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chromogranin) markers in foregut, midgut, and hindgut tumors
    • Nash S, Said J: Gastroenteropancreatic neuroendocrine tumors. A histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chromogranin) markers in foregut, midgut, and hindgut tumors. Am J Clin Pathol 1986; 86: 415-422.
    • (1986) Am J Clin Pathol , vol.86 , pp. 415-422
    • Nash, S.1    Said, J.2
  • 28
    • 0021153308 scopus 로고
    • Concurrent Cushing's and Zollinger- Ellison syndromes in a patient with islet cell carcinoma. Case report and review of the literature
    • Lyons D, Eisen B, Clark M, Pysher T, Welsh J, Kem D: Concurrent Cushing's and Zollinger- Ellison syndromes in a patient with islet cell carcinoma. Case report and review of the literature. Am J Med 1984; 76: 729-733.
    • (1984) Am J Med , vol.76 , pp. 729-733
    • Lyons, D.1    Eisen, B.2    Clark, M.3    Pysher, T.4    Welsh, J.5    Kem, D.6
  • 30
    • 39749182242 scopus 로고    scopus 로고
    • Pancreatic neuroendocrine tumours
    • O'Grady H, Conlon K: Pancreatic neuroendocrine tumours. Eur J Surg Oncol 2008; 34: 324-332.
    • (2008) Eur J Surg Oncol , vol.34 , pp. 324-332
    • O'Grady, H.1    Conlon, K.2
  • 31
    • 18844457312 scopus 로고    scopus 로고
    • Enteroendocrine tumors other than carcinoid: A review of clinically significant advances
    • Warner R: Enteroendocrine tumors other than carcinoid: A review of clinically significant advances. Gastroenterology 2005; 128: 1668-1684.
    • (2005) Gastroenterology , vol.128 , pp. 1668-1684
    • Warner, R.1
  • 32
    • 0022585306 scopus 로고
    • Secretion of chromogranin A by peptide-producing endocrine neoplasms
    • O'Connor D, Deftos L: Secretion of chromogranin A by peptide-producing endocrine neoplasms. N Engl J Med 1986; 314: 1145-1151.
    • (1986) N Engl J Med , vol.314 , pp. 1145-1151
    • O'Connor, D.1    Deftos, L.2
  • 33
    • 0030739137 scopus 로고    scopus 로고
    • Chromogranin A as serum marker for neuroendocrine neoplasia: Comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones
    • Nobels F, Kwekkeboom D, Coopmans W, et al: Chromogranin A as serum marker for neuroendocrine neoplasia: Comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. J Clin Endocrinol Metab 1997; 82: 2622-2628.
    • (1997) J Clin Endocrinol Metab , vol.82 , pp. 2622-2628
    • Nobels, F.1    Kwekkeboom, D.2    Coopmans, W.3
  • 35
    • 0027436147 scopus 로고
    • Comparison of plasma pancreastatin and GAWK concentrations, presumed processing products of chromogranin A and B, in plasma of patients with pancreatic islet cell tumors
    • Yasuda D, Iguchi H, Funakoshi A, Wakasugi H, Sekiya K, Misawa T, et al: Comparison of plasma pancreastatin and GAWK concentrations, presumed processing products of chromogranin A and B, in plasma of patients with pancreatic islet cell tumors. Horm Metab Res 1993; 25: 593-595.
    • (1993) Horm Metab Res , vol.25 , pp. 593-595
    • Yasuda, D.1    Iguchi, H.2    Funakoshi, A.3    Wakasugi, H.4    Sekiya, K.5    Misawa, T.6
  • 36
    • 8444241166 scopus 로고    scopus 로고
    • Neoplasms of the endocrine pancreas
    • Greenfield L, Mulholland M, Oldham K, et al: ed 3. Philadelphia, Lippincott
    • Yeo C: Neoplasms of the endocrine pancreas; in Greenfield L, Mulholland M, Oldham K, et al: Surgery: Scientific Principles and Practice, ed 3. Philadelphia, Lippincott, 2001, pp 899-913.
    • (2001) Surgery: Scientific Principles and Practice , pp. 899-913
    • Yeo, C.1
  • 37
    • 0344876161 scopus 로고    scopus 로고
    • Proinsulin- secreting neuroendocrine tumor of the pancreas
    • Piovesan A, Pia A, Visconti G, et al: Proinsulin- secreting neuroendocrine tumor of the pancreas. J Endocrinol Invest 2003; 26: 758-761.
    • (2003) J Endocrinol Invest , vol.26 , pp. 758-761
    • Piovesan, A.1    Pia, A.2    Visconti, G.3
  • 38
    • 0028594015 scopus 로고    scopus 로고
    • Assessment of immunoassays for insulin in diagnostic tests for insulinoma
    • Shimizu T, Sasakuma F, Ishikawa O, et al: Assessment of immunoassays for insulin in diagnostic tests for insulinoma. Diabetes Res Clin Pract 2003; 26: 149-154.
    • (2003) Diabetes Res Clin Pract , vol.26 , pp. 149-154
    • Shimizu, T.1    Sasakuma, F.2    Ishikawa, O.3
  • 39
    • 0344897787 scopus 로고    scopus 로고
    • Insulin levels measured with an insulin-specific assay in patients with fasting hypoglycaemia related to endogenous hyperinsulinism
    • Vezzosi D, Bennet A, Fauvel J, et al: Insulin levels measured with an insulin-specific assay in patients with fasting hypoglycaemia related to endogenous hyperinsulinism. Eur J Endocrinol 2003; 149: 413-419.
    • (2003) Eur J Endocrinol , vol.149 , pp. 413-419
    • Vezzosi, D.1    Bennet, A.2    Fauvel, J.3
  • 41
    • 2942675021 scopus 로고    scopus 로고
    • The diagnosis and medical management of advanced neuroendocrine tumors
    • Kaltsas G, Besser G, Grossman A: The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev 2004; 25: 458-511.
    • (2004) Endocr Rev , vol.25 , pp. 458-511
    • Kaltsas, G.1    Besser, G.2    Grossman, A.3
  • 42
    • 0033833356 scopus 로고    scopus 로고
    • Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas
    • Anderson M, Carpenter S, Thompson N, et al: Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 2000; 95: 2271-2277.
    • (2000) Am J Gastroenterol , vol.95 , pp. 2271-2277
    • Anderson, M.1    Carpenter, S.2    Thompson, N.3
  • 43
    • 0034839132 scopus 로고    scopus 로고
    • Assessment of selective arterial calcium stimulation and hepatic venous sampling to localize insulin-secreting tumours
    • Brandle M, Pfammatter T, Spinas G, et al: Assessment of selective arterial calcium stimulation and hepatic venous sampling to localize insulin-secreting tumours. Clin Endocrinol 2001; 55: 357-362.
    • (2001) Clin Endocrinol , vol.55 , pp. 357-362
    • Brandle, M.1    Pfammatter, T.2    Spinas, G.3
  • 44
    • 34748835270 scopus 로고    scopus 로고
    • Comparison of 68 Ga-DOTATOC PET and 111 In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours
    • Buchmann I, Henze M, Engelbrecht S, Eisenhut M, Runz A, Schafer M, et al: Comparison of 68 Ga-DOTATOC PET and 111 In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2007; 34: 1617-1626.
    • (2007) Eur J Nucl Med Mol Imaging , vol.34 , pp. 1617-1626
    • Buchmann, I.1    Henze, M.2    Engelbrecht, S.3    Eisenhut, M.4    Runz, A.5    Schafer, M.6
  • 45
    • 0035199692 scopus 로고    scopus 로고
    • Imaging appearances of metastases from neuroendocrine tumours of the pancreas
    • Debray M, Geoffroy O, Laissy J, et al: Imaging appearances of metastases from neuroendocrine tumours of the pancreas. Br J Radiol 2001; 74: 1065-1070.
    • (2001) Br J Radiol , vol.74 , pp. 1065-1070
    • Debray, M.1    Geoffroy, O.2    Laissy, J.3
  • 46
    • 0037024519 scopus 로고    scopus 로고
    • The role of PET in localization of neuroendocrine and adrenocortical tumors
    • Eriksson B, Bergstrom M, Sundin A, et al: The role of PET in localization of neuroendocrine and adrenocortical tumors. Ann NY Acad Sci 2002; 970: 159-169.
    • (2002) Ann NY Acad Sci , vol.970 , pp. 159-169
    • Eriksson, B.1    Bergstrom, M.2    Sundin, A.3
  • 47
    • 4344679124 scopus 로고    scopus 로고
    • Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours
    • Kaltsas G, Rockall A, Papadogias D, Reznek R, Grossman A: Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours. Eur J Endocrinol 2004; 151: 15-27.
    • (2004) Eur J Endocrinol , vol.151 , pp. 15-27
    • Kaltsas, G.1    Rockall, A.2    Papadogias, D.3    Reznek, R.4    Grossman, A.5
  • 48
    • 0032887684 scopus 로고    scopus 로고
    • Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: Bone scintigraphy compared with somatostatin receptor scintigraphy
    • Lebtahi R, Cardiot G, Delahaye N, et al: Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy. J Nucl Med 1999; 49: 1602-1608.
    • (1999) J Nucl Med , vol.49 , pp. 1602-1608
    • Lebtahi, R.1    Cardiot, G.2    Delahaye, N.3
  • 49
    • 3442884868 scopus 로고    scopus 로고
    • Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system
    • Oberg K, Kvols L, Caplin M, Delle Fave G, De Herder W, Rindi G, et al: Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol 2004; 15: 966-973.
    • (2004) Ann Oncol , vol.15 , pp. 966-973
    • Oberg, K.1    Kvols, L.2    Caplin, M.3    Delle Fave, G.4    De Herder, W.5    Rindi, G.6
  • 50
    • 0026642439 scopus 로고
    • Localization of gastrinomas by endoscopic ultrasonography
    • Rosch T, Lighdale C, Botet J, et al: Localization of gastrinomas by endoscopic ultrasonography. N Engl J Med 1992; 326: 1721-1726.
    • (1992) N Engl J Med , vol.326 , pp. 1721-1726
    • Rosch, T.1    Lighdale, C.2    Botet, J.3
  • 51
    • 0028841178 scopus 로고
    • Helical CT for the preoperative localisation of islet cell tumors of the pancreas: Value of arterial and parenchymal phase images
    • van Hoe L, Gryspeerdt S, Marchal G, et al: Helical CT for the preoperative localisation of islet cell tumors of the pancreas: Value of arterial and parenchymal phase images. Am J Roentgenol 1995; 165: 1437-1439.
    • (1995) Am J Roentgenol , vol.165 , pp. 1437-1439
    • Van Hoe, L.1    Gryspeerdt, S.2    Marchal, G.3
  • 52
    • 33745937110 scopus 로고    scopus 로고
    • Update on pancreatic endocrine tumors
    • Frankel W: Update on pancreatic endocrine tumors. Arch Pathol Lab Med 2006; 130: 963-966.
    • (2006) Arch Pathol Lab Med , vol.130 , pp. 963-966
    • Frankel, W.1
  • 53
    • 0034922464 scopus 로고    scopus 로고
    • Immunocytochemical localization of prohormone convertase 1/3 and 2 in pancreatic islet cells and islet cell tumors
    • Tomita T: Immunocytochemical localization of prohormone convertase 1/3 and 2 in pancreatic islet cells and islet cell tumors. Pancreas 2001; 23: 172-176.
    • (2001) Pancreas , vol.23 , pp. 172-176
    • Tomita, T.1
  • 54
    • 0028131801 scopus 로고
    • Expression of chromogranin A and B and secretoneurin immunoreactivity in neoplastic and nonneoplastic pancreatic alpha cells
    • Schmid K, Brink M, Freytag G, et al: Expression of chromogranin A and B and secretoneurin immunoreactivity in neoplastic and nonneoplastic pancreatic alpha cells. Virchows Arch 1994; 425: 127-132.
    • (1994) Virchows Arch , vol.425 , pp. 127-132
    • Schmid, K.1    Brink, M.2    Freytag, G.3
  • 55
    • 0018163442 scopus 로고
    • Neuron-specific enolase is a molecular marker for peripheral and central neuroendocrine cells
    • Schmechel D, Marangos P, Brightman M: Neuron-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature 1978; 276: 834-836.
    • (1978) Nature , vol.276 , pp. 834-836
    • Schmechel, D.1    Marangos, P.2    Brightman, M.3
  • 56
    • 0034816994 scopus 로고    scopus 로고
    • Chromogranin A in human neuroendocrine tumors. An immunohistochemical study with region-specific antibodies
    • Portela-Gomes G, Grimelius L, Johansson H, et al: Chromogranin A in human neuroendocrine tumors. An immunohistochemical study with region-specific antibodies. Am J Surg Pathol 2001; 25: 1261-1267.
    • (2001) Am J Surg Pathol , vol.25 , pp. 1261-1267
    • Portela-Gomes, G.1    Grimelius, L.2    Johansson, H.3
  • 57
    • 0033820166 scopus 로고    scopus 로고
    • Synaptic vesicle protein 2: A new neuroendocrine cell marker
    • Portela-Gomes G, Lukinius A, Grimelius L: Synaptic vesicle protein 2: A new neuroendocrine cell marker. Am J Clin Pathol 2000; 157: 1299-1309.
    • (2000) Am J Clin Pathol , vol.157 , pp. 1299-1309
    • Portela-Gomes, G.1    Lukinius, A.2    Grimelius, L.3
  • 58
    • 0032977310 scopus 로고    scopus 로고
    • Co-localization of synaptophysin with different neuroendocrine hormones in the human gastrointestinal tract
    • Portela-Gomes G, Stridsberg M, Johansson H, et al: Co-localization of synaptophysin with different neuroendocrine hormones in the human gastrointestinal tract. Histochem Cell Biol 1999; 111: 49-54.
    • (1999) Histochem Cell Biol , vol.111 , pp. 49-54
    • Portela-Gomes, G.1    Stridsberg, M.2    Johansson, H.3
  • 59
    • 0030914870 scopus 로고    scopus 로고
    • Complex co-localization of chromogranins and neurohormones in the human gastrointestinal tract
    • Portela-Gomes G, Stridsberg M, Johansson H, et al: Complex co-localization of chromogranins and neurohormones in the human gastrointestinal tract. J Histochem Cytochem 1997; 45: 815-822.
    • (1997) J Histochem Cytochem , vol.45 , pp. 815-822
    • Portela-Gomes, G.1    Stridsberg, M.2    Johansson, H.3
  • 60
    • 0036039961 scopus 로고    scopus 로고
    • Expression of somatostatin receptor and effects of somatostatin analogue on pancreatic endocrine tumors
    • Oda Y, Tanaka Y, Naruse T, et al: Expression of somatostatin receptor and effects of somatostatin analogue on pancreatic endocrine tumors. Surg Today 2002; 32: 690-694.
    • (2002) Surg Today , vol.32 , pp. 690-694
    • Oda, Y.1    Tanaka, Y.2    Naruse, T.3
  • 61
    • 0036271475 scopus 로고    scopus 로고
    • Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis
    • Papoti M, Bongiovanni M, Volante M, et al: Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis. Virchows Arch 2002; 440: 461-475.
    • (2002) Virchows Arch , vol.440 , pp. 461-475
    • Papoti, M.1    Bongiovanni, M.2    Volante, M.3
  • 62
    • 0036135375 scopus 로고    scopus 로고
    • Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies
    • Kulaksiz H, Eissele R, Rossler D, et al: Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies. Gut 2002; 50: 52-60.
    • (2002) Gut , vol.50 , pp. 52-60
    • Kulaksiz, H.1    Eissele, R.2    Rossler, D.3
  • 63
    • 0036724350 scopus 로고    scopus 로고
    • Neuropilin- is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours
    • Cohen T, Herzog Y, Brodzky A, et al: Neuropilin- is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours. J Pathol 2002; 198: 77-82.
    • (2002) J Pathol , vol.198 , pp. 77-82
    • Cohen, T.1    Herzog, Y.2    Brodzky, A.3
  • 65
    • 37649022748 scopus 로고    scopus 로고
    • Determining prognosis in patients with pancreatic endocrine neoplasms: Can the WHO classification system be simplified?
    • Ferrone C, Tang L, Tomlinson J, Gonene M, Hochwald S, Brennan M, et al: Determining prognosis in patients with pancreatic endocrine neoplasms: Can the WHO classification system be simplified? J Clin Oncol 2007; 25: 5609-5615.
    • (2007) J Clin Oncol , vol.25 , pp. 5609-5615
    • Ferrone, C.1    Tang, L.2    Tomlinson, J.3    Gonene, M.4    Hochwald, S.5    Brennan, M.6
  • 66
    • 0025108509 scopus 로고
    • Proposal for a new carcinoid tumour staging system based on tumour tissue infiltration and primary metastasis; A prospective multicentre carcinoid tumour evaluation study
    • West German Surgical Oncologists' Group
    • Moesta KT, Schlag P: Proposal for a new carcinoid tumour staging system based on tumour tissue infiltration and primary metastasis; a prospective multicentre carcinoid tumour evaluation study. West German Surgical Oncologists' Group. Eur J Surg Oncol 1990; 16: 280-288.
    • (1990) Eur J Surg Oncol , vol.16 , pp. 280-288
    • Moesta, K.T.1    Schlag, P.2
  • 67
    • 0029769005 scopus 로고    scopus 로고
    • Prognostic criteria in nonfunctioning pancreatic endocrine tumors
    • La Rosa S, Sessa F, Capella C, et al: Prognostic criteria in nonfunctioning pancreatic endocrine tumors. Virch Arch 1996; 429: 323-333.
    • (1996) Virch Arch , vol.429 , pp. 323-333
    • La Rosa, S.1    Sessa, F.2    Capella, C.3
  • 68
    • 0036605747 scopus 로고    scopus 로고
    • Prognostic factors in pancreatic endocrine neoplasms: An analysis of 136 cases with a proposal for low-grade and intermediate-grade groups
    • Hochwald S, Zee S, Conlon K, et al: Prognostic factors in pancreatic endocrine neoplasms: An analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol 2002; 20: 2633-2642.
    • (2002) J Clin Oncol , vol.20 , pp. 2633-2642
    • Hochwald, S.1    Zee, S.2    Conlon, K.3
  • 69
    • 33847662572 scopus 로고    scopus 로고
    • Malignant nonfunctioning endocrine tumors of the pancreas: Predictive factors for survival after surgical treatment
    • Chung J, Choi D, Jo S, Heo J, Choi S, Kim Y: Malignant nonfunctioning endocrine tumors of the pancreas: Predictive factors for survival after surgical treatment. World J Surg 2007; 31: 579-585.
    • (2007) World J Surg , vol.31 , pp. 579-585
    • Chung, J.1    Choi, D.2    Jo, S.3    Heo, J.4    Choi, S.5    Kim, Y.6
  • 71
    • 0042074384 scopus 로고    scopus 로고
    • Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenenctomy in high-risk patients and elimination of surgeon-related factors: Prospective, randomized, controlled trial
    • Shan Y, Sy E, Lin P: Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenenctomy in high-risk patients and elimination of surgeon-related factors: Prospective, randomized, controlled trial. World J Surg 2003; 27: 709-714.
    • (2003) World J Surg , vol.27 , pp. 709-714
    • Shan, Y.1    Sy, E.2    Lin, P.3
  • 72
    • 0029946787 scopus 로고    scopus 로고
    • Efficacy of somatostatin and its analogues in pancreatic surgery and pancreatic disorders
    • Friess H, Buchler M: Efficacy of somatostatin and its analogues in pancreatic surgery and pancreatic disorders. Digestion 1996; 57(suppl 1):97-102.
    • (1996) Digestion , vol.57 , Issue.SUPPL. 1 , pp. 97-102
    • Friess, H.1    Buchler, M.2
  • 73
    • 34347331314 scopus 로고    scopus 로고
    • Middle pancreatectomy: Indications, short- and long-term operative outcomes
    • Crippa S, Basi C, Warshaw A, Falconi M, Partelli S, Thayer S, et al: Middle pancreatectomy: indications, short- and long-term operative outcomes. Ann Surg 2007; 246: 69-76.
    • (2007) Ann Surg , vol.246 , pp. 69-76
    • Crippa, S.1    Basi, C.2    Warshaw, A.3    Falconi, M.4    Partelli, S.5    Thayer, S.6
  • 74
    • 0026628941 scopus 로고
    • Carcinoma of the body and tail of the pancreas: Is curative resection justified?
    • Dalton R, Sarr M, van Heerden J, Colby T: Carcinoma of the body and tail of the pancreas: is curative resection justified? Surgery 1992; 111: 489-494.
    • (1992) Surgery , vol.111 , pp. 489-494
    • Dalton, R.1    Sarr, M.2    Van Heerden, J.3    Colby, T.4
  • 75
    • 0027504081 scopus 로고
    • Surgical experience with pancreatic islet-cell tumors
    • Yeo C, Wang B, Anthone G, Cameron J: Surgical experience with pancreatic islet-cell tumors. Arch Surg 1993; 128: 1143-1148.
    • (1993) Arch Surg , vol.128 , pp. 1143-1148
    • Yeo, C.1    Wang, B.2    Anthone, G.3    Cameron, J.4
  • 76
    • 0024269998 scopus 로고
    • Islet cell carcinomas of the pancreas: A twenty-year experience
    • Thompson G, van Heerden J, Grant C, Carney J, Ilstrup D: Islet cell carcinomas of the pancreas: A twenty-year experience. Surgery 1988; 104: 1011-1017.
    • (1988) Surgery , vol.104 , pp. 1011-1017
    • Thompson, G.1    Van Heerden, J.2    Grant, C.3    Carney, J.4    Ilstrup, D.5
  • 80
    • 0027215155 scopus 로고
    • Management of non-functioning neuroendocrine tumours of the pancreas
    • Cheslyn-Curtis S, Sitaram V, Williamson R: Management of non-functioning neuroendocrine tumours of the pancreas. Br J Surg 1993; 80: 625-627.
    • (1993) Br J Surg , vol.80 , pp. 625-627
    • Cheslyn-Curtis, S.1    Sitaram, V.2    Williamson, R.3
  • 82
    • 35148863221 scopus 로고    scopus 로고
    • Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: Analysis of 9,821 patients
    • Billimoria K, Tomlinson J, Merkow R, Stewart A, Ko C, Talamonti M, et al: Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: Analysis of 9,821 patients. J Gastrointest Surg 2007; 11: 1460-1467.
    • (2007) J Gastrointest Surg , vol.11 , pp. 1460-1467
    • Billimoria, K.1    Tomlinson, J.2    Merkow, R.3    Stewart, A.4    Ko, C.5    Talamonti, M.6
  • 83
    • 10744226309 scopus 로고    scopus 로고
    • Aggressive surgery for metastatic liver neuroendocrine tumors
    • Norton J, Warren R, Kelly M, Zuraek M, Jensen R: Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery 2003; 134: 1057-1063.
    • (2003) Surgery , vol.134 , pp. 1057-1063
    • Norton, J.1    Warren, R.2    Kelly, M.3    Zuraek, M.4    Jensen, R.5
  • 84
    • 0037635397 scopus 로고    scopus 로고
    • Surgical treatment of neuroendocrine metastases to the liver: A plea for resection to increase survival
    • Sarmiento J, Heywood G, Rubin J, Ilstrup D, Nagorney D, Que F: Surgical treatment of neuroendocrine metastases to the liver: A plea for resection to increase survival. J Am Coll Surg 2003; 197: 29-37.
    • (2003) J Am Coll Surg , vol.197 , pp. 29-37
    • Sarmiento, J.1    Heywood, G.2    Rubin, J.3    Ilstrup, D.4    Nagorney, D.5    Que, F.6
  • 86
  • 89
    • 33947354249 scopus 로고    scopus 로고
    • Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumours
    • Olausson M, Friman S, Herlenius G, Cahlin C, Nilsson O, Jansson S, et al: Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumours. Liver Transplant 2007; 13: 327-333.
    • (2007) Liver Transplant , vol.13 , pp. 327-333
    • Olausson, M.1    Friman, S.2    Herlenius, G.3    Cahlin, C.4    Nilsson, O.5    Jansson, S.6
  • 90
    • 34548684358 scopus 로고    scopus 로고
    • Role of liver transplantation in the management of unresectable neuroendocrine liver metastases
    • Marin C, Robles R, Fernandez J, Bueno F, Ramirez P, Miras M, et al: Role of liver transplantation in the management of unresectable neuroendocrine liver metastases. Transplant Proc 2007; 39: 2302-2303.
    • (2007) Transplant Proc , vol.39 , pp. 2302-2303
    • Marin, C.1    Robles, R.2    Fernandez, J.3    Bueno, F.4    Ramirez, P.5    Miras, M.6
  • 91
    • 0032855909 scopus 로고    scopus 로고
    • Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - A single center experience with ten patients
    • Lang H, Schlitt H, Schmidt H, Felemming P, Nashan B, Scheumann G, et al: Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients. Langenbecks Arch Surg 1999; 384: 370-377.
    • (1999) Langenbecks Arch Surg , vol.384 , pp. 370-377
    • Lang, H.1    Schlitt, H.2    Schmidt, H.3    Felemming, P.4    Nashan, B.5    Scheumann, G.6
  • 92
    • 0035040838 scopus 로고    scopus 로고
    • Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours
    • Aparicio T, Ducreux M, Baudin E, Sabourin J, De Baere T, Mitry E, et al: Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours. Eur J Cancer 2001; 37: 1014-1019.
    • (2001) Eur J Cancer , vol.37 , pp. 1014-1019
    • Aparicio, T.1    Ducreux, M.2    Baudin, E.3    Sabourin, J.4    De Baere, T.5    Mitry, E.6
  • 94
    • 33747635920 scopus 로고    scopus 로고
    • Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours
    • Hubina E, Nanzer A, Hanson M, Ciccarelli E, Losa M, Gaia D, et al: Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours. Eur J Endocrinol 2006; 155: 371-379.
    • (2006) Eur J Endocrinol , vol.155 , pp. 371-379
    • Hubina, E.1    Nanzer, A.2    Hanson, M.3    Ciccarelli, E.4    Losa, M.5    Gaia, D.6
  • 95
    • 17944362339 scopus 로고    scopus 로고
    • [177Lu-DOTAOTyr3]octreotate: Comparison with [111In-DTPAo]octreotide in patients
    • Kwekkeboom D, Bakker W, Kooij P, et al: [177Lu-DOTAOTyr3]octreotate: Comparison with [111In-DTPAo]octreotide in patients. Eur J Nucl Med 2001; 28: 1319-1325.
    • (2001) Eur J Nucl Med , vol.28 , pp. 1319-1325
    • Kwekkeboom, D.1    Bakker, W.2    Kooij, P.3
  • 96
    • 0032926897 scopus 로고    scopus 로고
    • Anti-proliferative effect of radiolabelled octreotide in a metastases model in rat liver
    • Slooter G, Breeman W, Marquet R, Krenning E, van Eijck C: Anti-proliferative effect of radiolabelled octreotide in a metastases model in rat liver. Int J Cancer 1999; 81: 767-771.
    • (1999) Int J Cancer , vol.81 , pp. 767-771
    • Slooter, G.1    Breeman, W.2    Marquet, R.3    Krenning, E.4    Van Eijck, C.5
  • 97
    • 21044451724 scopus 로고    scopus 로고
    • Radiolabeled somatostatin analog [177Lu- DOTA0, Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors
    • Kwekkeboom D, Teunissen J, Bakker W, Kooij P, De Herder W, Feelders R, et al: Radiolabeled somatostatin analog [177Lu- DOTA0, Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors. J Clin Oncol 2005; 23: 2754-2762.
    • (2005) J Clin Oncol , vol.23 , pp. 2754-2762
    • Kwekkeboom, D.1    Teunissen, J.2    Bakker, W.3    Kooij, P.4    De Herder, W.5    Feelders, R.6
  • 100
    • 6044249072 scopus 로고    scopus 로고
    • Chemotherapy for gastro-enteropancreatic endocrine tumours
    • O'Toole D, Hentic O, Corcos O, Ruszniewski P: Chemotherapy for gastro-enteropancreatic endocrine tumours. Neuroendocrinology 2004; 80(suppl 1):79-84.
    • (2004) Neuroendocrinology , vol.80 , Issue.SUPPL. 1 , pp. 79-84
    • O'Toole, D.1    Hentic, O.2    Corcos, O.3    Ruszniewski, P.4
  • 101
    • 0026530547 scopus 로고
    • Streptozocin-doxurubicin, streptozocinfluorouracil of chlorozotocin in the treatment of advanced islet-cell carcinoma
    • Moertel C, Lefkopoulos M, Lipsitz M: Streptozocin-doxurubicin, streptozocinfluorouracil of chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med 1992; 326: 519-523.
    • (1992) N Engl J Med , vol.326 , pp. 519-523
    • Moertel, C.1    Lefkopoulos, M.2    Lipsitz, M.3
  • 102
    • 0034823957 scopus 로고    scopus 로고
    • Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma
    • Study of the Eastern Cooperative Oncology Group-E6282
    • Ramanathan R, Cnaan A, Hahn R, et al: Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282. Ann Oncol 2001; 12: 1139-1143.
    • (2001) Ann Oncol , vol.12 , pp. 1139-1143
    • Ramanathan, R.1    Cnaan, A.2    Hahn, R.3
  • 103
    • 18844464572 scopus 로고    scopus 로고
    • 5- Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors
    • Bajetta E, Rimasa L, Camaghi C, et al: 5- Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors. Cancer 1998; 83: 372-378.
    • (1998) Cancer , vol.83 , pp. 372-378
    • Bajetta, E.1    Rimasa, L.2    Camaghi, C.3
  • 104
    • 0032734719 scopus 로고    scopus 로고
    • Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
    • Mitry E, Baudin E, Ducreux M, Sabourin J, Rufie P, Aparicio T, et al: Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer 1999; 81: 1351-1355.
    • (1999) Br J Cancer , vol.81 , pp. 1351-1355
    • Mitry, E.1    Baudin, E.2    Ducreux, M.3    Sabourin, J.4    Rufie, P.5    Aparicio, T.6
  • 105
    • 0025933213 scopus 로고
    • Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms
    • Moertel C, Kvols L, O'Connell M, Rubin J: Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer 1991; 68: 227-232.
    • (1991) Cancer , vol.68 , pp. 227-232
    • Moertel, C.1    Kvols, L.2    O'Connell, M.3    Rubin, J.4
  • 106
    • 0022921873 scopus 로고
    • Phase II study of cisplatin therapy in patients with metastatic carcinoid tumor and the malignant carcinoid syndrome
    • Moertel C, Rubin J, O'Connell M: Phase II study of cisplatin therapy in patients with metastatic carcinoid tumor and the malignant carcinoid syndrome. Cancer Treatment Rep 1986; 70: 1459-1460.
    • (1986) Cancer Treatment Rep , vol.70 , pp. 1459-1460
    • Moertel, C.1    Rubin, J.2    O'Connell, M.3
  • 108
    • 0028872404 scopus 로고
    • A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours
    • A study by the Italian Trial in Medical Oncology (I.T.M.O.) Group
    • Di Bartolomeo M, Bajetta E, Bochicchio AM, et al: A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trial in Medical Oncology (I.T.M.O.) Group. Ann Oncol 1995; 6: 77-79.
    • (1995) Ann Oncol , vol.6 , pp. 77-79
    • Di Bartolomeo, M.1    Bajetta, E.2    Bochicchio, A.M.3
  • 109
    • 0033847685 scopus 로고    scopus 로고
    • Interferon in the management of neuroendocrine GEP-tumours
    • Oberg K: Interferon in the management of neuroendocrine GEP-tumours. Digestion 2000; 62(suppl 1):92-97.
    • (2000) Digestion , vol.62 , Issue.SUPPL. 1 , pp. 92-97
    • Oberg, K.1
  • 110
    • 0019222419 scopus 로고
    • Synthesis in E. coli of a polypeptide with human leukocyte interferon activity
    • Nagata S, Taira H, Hall A, Johnsrud L, Streuli M, Ecsodi J, et al: Synthesis in E. coli of a polypeptide with human leukocyte interferon activity. Nature 1980; 284: 316-320.
    • (1980) Nature , vol.284 , pp. 316-320
    • Nagata, S.1    Taira, H.2    Hall, A.3    Johnsrud, L.4    Streuli, M.5    Ecsodi, J.6
  • 111
    • 0029987910 scopus 로고    scopus 로고
    • Longterm results of continuous treatment with recombinant interferon-alpha in patients with metastatic carcinoid tumors - An antiangiogenic effect?
    • Dirix L, Vermeulen P, Fierens H, De Schepper B, Corthouts B, Van Oosterom A: Longterm results of continuous treatment with recombinant interferon-alpha in patients with metastatic carcinoid tumors - an antiangiogenic effect? Anticancer Drugs 1996; 7: 175-181.
    • (1996) Anticancer Drugs , vol.7 , pp. 175-181
    • Dirix, L.1    Vermeulen, P.2    Fierens, H.3    De Schepper, B.4    Corthouts, B.5    Van Oosterom, A.6
  • 112
    • 0025986704 scopus 로고
    • The role of interferons in the management of carcinoid tumours
    • Oberg K, Eriksson B: The role of interferons in the management of carcinoid tumours. Br J Haematol 1991; 79(suppl 1):74-77.
    • (1991) Br J Haematol , vol.79 , Issue.SUPPL. 1 , pp. 74-77
    • Oberg, K.1    Eriksson, B.2
  • 113
    • 0043132282 scopus 로고    scopus 로고
    • Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors - The International Lanreotide and Interferon Alfa Study Group
    • Faiss S, Pape U, Bohmig M, Dorffel Y, Mansmann U, Golder W, et al: Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors - the International Lanreotide and Interferon Alfa Study Group. J Clin Oncol 2003; 21: 2689-2696.
    • (2003) J Clin Oncol , vol.21 , pp. 2689-2696
    • Faiss, S.1    Pape, U.2    Bohmig, M.3    Dorffel, Y.4    Mansmann, U.5    Golder, W.6
  • 114
    • 33846473731 scopus 로고    scopus 로고
    • Interferon-alpha and somatostatin analog in patients with gastroenteropancreatic neuroendocrine carcinoma: Single agent or combination
    • Fazio N, De Braud F, Delle Fave G, Oberg K: Interferon-alpha and somatostatin analog in patients with gastroenteropancreatic neuroendocrine carcinoma: single agent or combination. Ann Oncol 2007; 18: 13-19.
    • (2007) Ann Oncol , vol.18 , pp. 13-19
    • Fazio, N.1    De Braud, F.2    Delle Fave, G.3    Oberg, K.4
  • 115
    • 0036015230 scopus 로고    scopus 로고
    • Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs
    • Fjallskog M, Sundin A, Westlin J, Oberg K, Janson E, Eriksson B: Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs. Med Oncol 2002; 19: 35-42.
    • (2002) Med Oncol , vol.19 , pp. 35-42
    • Fjallskog, M.1    Sundin, A.2    Westlin, J.3    Oberg, K.4    Janson, E.5    Eriksson, B.6
  • 117
    • 0032721914 scopus 로고    scopus 로고
    • Therapeutic and diagnostic implications of the somatostatin system in gastroenteropancreatic neuroendocrine tumour disease
    • Hocker M, Wiedenmann B: Therapeutic and diagnostic implications of the somatostatin system in gastroenteropancreatic neuroendocrine tumour disease. Ital J Gastroenterol Hepatol 1999; 31(suppl 2):S139-S142.
    • (1999) Ital J Gastroenterol Hepatol , vol.31 , Issue.SUPPL. 2
    • Hocker, M.1    Wiedenmann, B.2
  • 118
    • 1842524986 scopus 로고    scopus 로고
    • Considerations concerning a tailored individualized therapeutic management of patients with (neuro)endocrine tumours of the gastrointestinal tract and pancreas
    • De Herder W, Krenning E, van Eijck C, Lamberts S: Considerations concerning a tailored individualized therapeutic management of patients with (neuro)endocrine tumours of the gastrointestinal tract and pancreas. Endocr Relat Cancer 2004; 11: 19-34.
    • (2004) Endocr Relat Cancer , vol.11 , pp. 19-34
    • De Herder, W.1    Krenning, E.2    Van Eijck, C.3    Lamberts, S.4
  • 119
    • 33845594007 scopus 로고    scopus 로고
    • Treatment with 90Y-and 177Lu-DOTATOC in patients with metastatic neuroendocrine tumors
    • Frilling A, Weber F, Saner F, Bockisch A, Hofmann M, Mueller-Brand J, et al: Treatment with 90Y-and 177Lu-DOTATOC in patients with metastatic neuroendocrine tumors. Surgery 2006; 140: 968-977.
    • (2006) Surgery , vol.140 , pp. 968-977
    • Frilling, A.1    Weber, F.2    Saner, F.3    Bockisch, A.4    Hofmann, M.5    Mueller-Brand, J.6
  • 120
    • 0347087585 scopus 로고    scopus 로고
    • Ablative therapies for liver metastases of digestive endocrine tumours
    • O'Toole D, Maire F, Ruszniewski P: Ablative therapies for liver metastases of digestive endocrine tumours. Endocr Relat Cancer 2003; 10: 463-468.
    • (2003) Endocr Relat Cancer , vol.10 , pp. 463-468
    • O'Toole, D.1    Maire, F.2    Ruszniewski, P.3
  • 121
    • 34447094560 scopus 로고    scopus 로고
    • Complete eradication of hepatic metastasis from colorectal cancer by Yttrium-90 SIRT
    • Garren S, Muhs A, Bui J, Blend M, Owens C, Helton W, et al: Complete eradication of hepatic metastasis from colorectal cancer by Yttrium-90 SIRT. World J Gastroenterol 2007; 13: 3016-3019.
    • (2007) World J Gastroenterol , vol.13 , pp. 3016-3019
    • Garren, S.1    Muhs, A.2    Bui, J.3    Blend, M.4    Owens, C.5    Helton, W.6
  • 122
    • 7944226700 scopus 로고    scopus 로고
    • Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer
    • van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, et al: Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. J Surg Oncol 2004; 88: 78-85.
    • (2004) J Surg Oncol , vol.88 , pp. 78-85
    • Van Hazel, G.1    Blackwell, A.2    Anderson, J.3    Price, D.4    Moroz, P.5    Bower, G.6
  • 123
    • 34047203633 scopus 로고    scopus 로고
    • Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio
    • Gulec S, Mesoloras G, Dezarn W, McNeillie P, Kennedy A: Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio. J Transl Med 2007; 5: 15.
    • (2007) J Transl Med , vol.5 , pp. 15
    • Gulec, S.1    Mesoloras, G.2    Dezarn, W.3    McNeillie, P.4    Kennedy, A.5
  • 124
    • 0033135876 scopus 로고    scopus 로고
    • Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development
    • Gale N, Yancopoulos G: Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 1999; 13: 1055-1066.
    • (1999) Genes Dev , vol.13 , pp. 1055-1066
    • Gale, N.1    Yancopoulos, G.2
  • 126
    • 20444473802 scopus 로고    scopus 로고
    • Phase i clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours
    • Mross K, Drevs J, Muller M, Medinger M, Marme D, Hennig J, et al: Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours. Eur J Cancer 2005; 41: 1291-1299.
    • (2005) Eur J Cancer , vol.41 , pp. 1291-1299
    • Mross, K.1    Drevs, J.2    Muller, M.3    Medinger, M.4    Marme, D.5    Hennig, J.6
  • 127
    • 33645732568 scopus 로고    scopus 로고
    • Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): Translation of biological activity in a mouse melanoma metastasis model to phase i studies in patients with advanced colorectal cancer with liver metastases
    • Lee L, Sharma S, Morgan B, Allegrini P, Schnell C, Brueggen J, et al: Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): Translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases. Cancer Chemother Pharmacol 2006; 57: 761-771.
    • (2006) Cancer Chemother Pharmacol , vol.57 , pp. 761-771
    • Lee, L.1    Sharma, S.2    Morgan, B.3    Allegrini, P.4    Schnell, C.5    Brueggen, J.6
  • 129
    • 18344369461 scopus 로고    scopus 로고
    • PTK787/ZK 222584, a tyrosine kinase inhibitor of all known VEGF receptors, represses tumour growth with high efficacy
    • Hess-Stumpp H, Haberey M, Thierauch KH: PTK787/ZK 222584, a tyrosine kinase inhibitor of all known VEGF receptors, represses tumour growth with high efficacy. Chembiochem 2005; 6: 550-557.
    • (2005) Chembiochem , vol.6 , pp. 550-557
    • Hess-Stumpp, H.1    Haberey, M.2    Thierauch, K.H.3
  • 130
    • 0031867308 scopus 로고    scopus 로고
    • Isolated liver metastases from neuroendocrine tumors: Does resection prolong survival?
    • Chen H, Hardacre J, Uzar A, Cameron J, Choti M: Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 1998; 187: 88-92.
    • (1998) J Am Coll Surg , vol.187 , pp. 88-92
    • Chen, H.1    Hardacre, J.2    Uzar, A.3    Cameron, J.4    Choti, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.